Elevated plasma endothelin-1 level in streptozotocin-induced diabetic rats and responsiveness of the mesenteric arterial bed to endothelin-1

British Journal of Pharmacology

Volumn 123, Issue 6, 1998, Pages 1065-1072

  Makino, Ayako ^a   Kamata, Katsuo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Diabetes; Endothelin 1; Endothelium; ET(A) receptor; ET(B) receptor; Mesenteric arterial bed

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; GLUCOSE; METHOXAMINE; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; PERHYDRO 1 AZEPINYLCARBONYLLEUCYL DEXTRO TRYPTOPHYL DEXTRO TRYPTOPHAN; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE]; TRITON X 100; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BLOOD LEVEL; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIN-1; ENDOTHELINS; ENZYME INHIBITORS; MALE; MESENTERIC ARTERIES; NITROARGININE; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; STREPTOZOCIN; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 0031912321     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701704     Document Type: Article

References (41)

1. ABIRU, T., WATANABE, Y., KAMATA, K. & KASUYA, Y. (1993a). Simultaneous measurement of vasodilatation and changes in cyclic nucleotides in perfused mesenteric arterial bed of rat. Eur. J. Pharmacol., 242, 15-22.
2. ABIRU, T., WATANABE, Y., KAMATA, K. & KASUYA, Y. (1993b). Changes in endothelium-dependent relaxation and levels of cyclic nucleotides in the perfused mesenteric arterial bed from streptozotocin-induced diabetic rats. Life Sci., 53, PL7-12.
3. ARAI, H., HORI, S., ARAMORI, I., OHKUBO, H. & NAKANISHI, S. (1990). Cloning and expression of a cDNA encoding an endothelin receptor. Nature, 348, 730-732.
4. COLLIER, A., LEACH, J.P., MCLELLAN, A., JARDINE, A., MORTON, J.J. & SMALL, M. (1992). Plasma endothelin-like immunoreactivity levels in IDDM patients with microalbuminuria. Diabetes Care, 15, 1038-1040.
5. DE NUCCI, G., THOMAS, R., D'ORLEANS-JUSTE, P., ANTUNES, E., WALDER, C., WARNER, T.D. & VANE, J.R. (1988). Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. U.S.A., 85, 9797-9800.
6. D'ORLEANS-JUSTE, P., CLAING, A., WARNER, T.D., YANO, M. & TELEMAQUE, S. (1993). Characterization of receptors for endothelins in the perfused arterial and venous mesenteric vascultures of the rat. Br. J. Pharmacol., 110, 687-692.
7. DUBOWSKI, K.M. (1962). An O-toluidine method for body-fluid glucose determination. Clin. Chem., 8, 215-235.
8. 2, but not noradrenaline, of aortae from rats with streptozotocin-induced diabetes mellitus. Br. J. Pharmacol., 104, 928-932.
9. GOTO, K., HAMA, H. & KASUYA, Y. (1996). Molecular pharmacology and pathophysiological significance of endothelin. Jpn. J. Pharmacol., 72, 261-290.
10. HATTORI, Y., KASAI, K., NAKAMURA, T., EMOTO, T. & SHIMODA, S. (1991). Effect of glucose and insulin on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cells. Metabolism, 40, 165-169.
11. HIRATA, Y., YOSHIMI, H., TAKAICHI, S., YANAGISAWA, M. & MASAKI, T. (1988a). Binding and receptor down-regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. FEBS Lett., 239, 13-17.
12. HIRATA, Y., YOSHIMI, H., TAKATA, S., WATANABE, T.X., KUMAGAI, S., NAKAJIMA, K. & SAKAKIBARA, S. (1988b). Cellular mechanism of action by a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. Biochem. Biophys. Res. Commun., 154, 868-875.
13. HODGSON, W.C. & KING, R.G. (1992). Effects of glucose, insulin or aldose reductase inhibition on responses to endothelin-1 of aortic rings from streptozotocin-induced diabetic rats. Br. J. Pharmacol., 106, 644-649.
14. INOUE, A., YANAGISAWA, M., KIMURA, S., KASUYA, Y., MIYAUCHI, T., GOTO, K. & MASAKI, T. (1989). The human endothelin family: The structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl. Acad. Sci. U.S.A., 86, 2863-2867.
15. 1-adrenoceptor agonist. Br. J. Pharmacol., 120, 1221-1226.
16. KAMATA, K., MIYATA, N. & KASUYA, Y. (1989a). Impairment of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats. Br. J. Pharmacol., 87, 614-618.
17. KAMATA, K., MIYATA, N. & KASUYA, Y. (1989b). Involvement of endothelial cells in relaxation and contraction responses of the aorta to isoproterenol in native and streptozotocin-induced diabetic rats. J. Pharmacol. Exp. Ther., 249, 890-894.
18. KAMATA, K., MORI, T., SHIGENOBU, K. & KASUYA, Y. (1989c). Endothelium-dependent vasodilator effects of platelet activating factor on rat resistance vessels. Br. J. Pharmacol., 98, 1360-1364.
19. G-nitro-L-arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin-induced diabetes mellitus. Br. J. Pharmacol., 103, 1321-1326.
20. G-nitro-L-arginine methylester in streptozotocin-induced diabetes mellitus. Br. J. Pharmacol., 106, 1035.
21. LIEU, A.T. & REID, J.J. (1994). Changes in the responsiveness to endothelin-1 in isolated atria from diabetic rats. Eur. J. Pharmacol., 261, 33-42.
22. LUSCHER, T.F., OEMAR, B.S., BOULANGER, C.M. & HAHN, A.W.A. (1993). Molecular and cellular biology of endothelin and its receptors. Part II. J. Hypertens., 11, 7-11.
23. MCGREGOR, D.D. (1965). The effect of sympathetic nerve stimulation on vasoconstrictor responses in perfused mesenteric blood vessels of the rat. J. Physiol., 177, 21-30.
24. MIASIRO, N. & PAIVA, A.C.M. (1990). Homologous desensitization of the effects of endothelin on rabbit aorta rings and on cultured rat aorta smooth muscle cells. Eur. J. Pharmacol., 179, 151-158.
25. 125I]-endothelin-binding sites in rat cardiac membranes. Br. J. Pharmacol., 97, 993-995.
26. OYAMA, Y., KAWASAKI, H., HATTORI, Y. & KANNO, M. (1986). Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur. J. Pharmacol., 131, 75-78.
27. PIEPER, G.M. & GROSS, G.J. (1988). Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta. Am. J. Physiol., 255, H825-H833.
28. POSTON, L. & TAYLOR, P.D. (1995). Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin. Sci., 88, 245-255.
29. SAKURAI, T., YANAGISAWA, M., TAKUWA, Y., MIYAZAKI, H., KIMURA, S., GOTO, K. & MASAKI, T. (1990). Cloning of a cDNA encoding of a non-isopeptide-selective subtype of the endothelin receptor. Nature, 348, 732-734.
30. SHIN, S.J., LEE, Y.J., LIN, S.R., TAN, M.S., LAI, Y.H. & TSAI, J.H. (1995). Decrease of renal endothelin 1 content and gene expression in diabetic rats with moderate hyperglycemia. Nephron., 70, 486-493.
31. TADA, H., MURAMATSU, I., NAKAI, T., KIGOSHI, S. & MIYABO, S. (1994). Effects of chronic diabetes on the responsiveness to endothelin-1 and other agents of rat atria and thoracic aorta. Gen. Pharmacol., 25, 1221-1228.
32. TAKAHASHI, K., GHATEI, M.A., LAM, H.C., O'HALLORAN, D.J. & BLOOM, S.R. (1990). Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia, 33, 306-310.
33. TAKEDA, Y., MIYAMORI, I., YONEDA, T. & TAKEDA, R. (1991). Production of endothelin-1 from the mesenteric arteries of streptozotocin-induced diabetic rats. Life Sci., 48, 2553-2556.
34. THIEMERMANN, C., LIDBURY, P., THOMAS, R. & VANE, J. (1988). Endothelin inhibits ex vivo platelet aggregation in the rabbit. Eur. J. Pharmacol., 158, 181-182.
35. TOMLINSON, K.C., GARDINER, S.M., HEBDEN, A. & BENNETT, T. (1992). Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol. Rev., 44, 103-150.
36. TSUNODA, K., ABE, K., SATO, T., YOKOSAWA, S. & YOSHINAGA, K. (1991). Decreased conversion of big endothelin-1 to endothelin-1 in patients with diabetes mellitus. Clin. Exp. Pharmacol. Physiol., 18, 731.
37. WARNER, T.D. (1990). Simultaneous perfusion of rat isolated superior mesenteric arterial and venous beds: comparison of their vasoconstrictor and vasodilator responses to agonists. Br. J. Pharmacol., 99, 427-433.
38. WARNER. T.D., DE NUCCI, G. & VANE, J.R. (1989a). Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat. Eur. J. Pharmacol., 159, 325-326.
39. WARNER, T.D., MITCHELL, J.A., DENUECI, G. & VANE, R. (1989b). Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit. J. Cardiovasc. Pharmacol., 13, S85.
40. WRIGHT, C.E. & FOZARD, J.R. (1988). Regional vasodilation is a prominent feature of the haemodynamic response to endothelin in anaesthetized spontaneously hypertensive rats. Eur. J. Pharmacol., 155, 201-203.
41. YAMAUCHI, T., OHNAKA, K., TAKAYANAGI, R. & UMEDA, F. (1990). Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells. FEBS Lett., 267, 16-18.